Johnson & Johnson MedTech today announced several of its medical technologies businesses will be renamed.

。

The Ethicon, DePuy Synthes, Biosense Webster, Abiomed and Cerenovus businesses will now go by the J&J MedTech name. Johnson & Johnson

Ethicon、DePuy Synthes、Biosense Webster、Abiomed和Cerenovus的业务现在将更名为强生医疗技术公司。强生公司

(NYSE: JNJ)

（纽约证券交易所：JNJ）

+

+

said the rename is part of its updated brand and visual identity update, which was announced in September last year.

他表示，此次更名是其品牌和视觉标识更新的一部分，该更新于去年9月宣布。

This most recent rebrand will not impact the medical technology products J&J MedTech currently offers.

这一最新的品牌更名不会影响强生医疗科技目前提供的医疗技术产品。

“At Johnson & Johnson, we are addressing some of the largest unmet needs in healthcare through innovative medicine and medical technology. By bringing our medtech businesses together under the Johnson & Johnson name, the scale of our impact in healthcare will be even more apparent, unlocking new opportunities for us to strengthen our competitiveness,” said Tim Schmid, executive VP and worldwide chair of J&J MedTech..

强生公司执行副总裁兼全球总裁蒂姆·施密德（TimSchmid）表示：“在强生公司，我们正在通过创新医学和医疗技术来解决医疗保健领域一些最大的未满足需求。通过以强生公司的名义将我们的医疗技术业务整合在一起，我们在医疗保健领域的影响力将更加明显，为我们提供了增强竞争力的新机会。”。。

J&J said partners, customers and consumers will begin seeing rebrand changes on social media channels and marketing materials over the coming weeks. The updated brand and visual identity will not impact the J&J MedTech portfolio.

强生表示，未来几周，合作伙伴、客户和消费者将开始在社交媒体渠道和营销材料上看到品牌重塑的变化。更新后的品牌和视觉标识不会影响强生医疗技术产品组合。

“While Ethicon, DePuy Synthes, Biosense Webster, Abiomed, and Cerenovus will now go by Johnson & Johnson MedTech, we will continue to honor the legacies of these brands by maintaining the products, services and approach to collaboration that made them some of the most trusted names in healthcare,” Schmid said..

施密德说：“虽然Ethicon、DePuy Synthes、Biosense Webster、Abiomed和Cerenovus现在将由强生医疗科技公司（Johnson＆Johnson MedTech）管理，但我们将继续通过维护产品、服务和合作方式来尊重这些品牌的遗产，这些产品、服务和合作方式使它们成为医疗保健领域最值得信赖的品牌。”。。

More about Johnson & Johnson’s rebrand

关于强生公司更名的更多信息

Previously called Johnson & Johnson Medical Devices, the company rebranded the MedTech business unit in March 2022 as it moved deeper into digital technology.

该公司原名强生医疗器械公司（Johnson＆Johnson Medical Devices），于2022年3月更名为MedTech业务部门，以进一步进军数字技术领域。

Then, Johnson & Johnson announced in September last year that it rebranded with a new logo and name for its Janssen pharmaceutical business, one year after its MedTech business rebrand.

然后，强生公司于去年9月宣布，在其MedTech业务更名一年后，为其杨森制药业务更名为新徽标和名称。

The company replaced its 136-year-old logo with a “more modern logo and brighter red, keeping the iconic ampersand.” CEO Joaquin Duato said the change was meant to call attention to the company’s focus on innovative medicine and medtech.

该公司用“更现代的标志和更明亮的红色，保留了标志性的符号”取代了已有136年历史的标志。首席执行官Joaquin Duato表示，这一变化旨在引起人们对该公司专注于创新医学和医学技术的关注。

Johnson & Johnson MedTech is the second-largest medtech company in the world, according to Medical Design & Outsourcing‘s latest Medtech Big 100 ranking.

根据医疗设计与外包公司（Medical Design&Outsourcing）最新的医疗技术100强排名，强生医疗技术公司（Johnson＆Johnson MedTech）是世界第二大医疗技术公司。